Chatham Capital Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-508
| Closed | -$209K | – | 184 |
|
|
2022
Q1 | $209K | Sell |
508
-540
| -52% | -$211K | 0.04% | 175 |
|
|
2021
Q4 | $492K | Sell |
1,048
-157
| -13% | -$67.6K | 0.09% | 148 |
|
|
2021
Q3 | $512K | Hold |
1,205
| – | – | 0.1% | 144 |
|
|
2021
Q2 | $433K | Hold |
1,205
| – | – | 0.08% | 145 |
|
|
2021
Q1 | $340K | Hold |
1,205
| – | – | 0.07% | 154 |
|
|
2020
Q4 | $341K | Hold |
1,205
| – | – | 0.08% | 141 |
|
|
2020
Q3 | $331K | Hold |
1,205
| – | – | 0.08% | 132 |
|
|
2020
Q2 | $274K | Buy |
+1,205
| New | +$237K | 0.07% | 141 |
|
|
2020
Q1 | – | Sell |
-12,931
| Closed | -$1.94M | – | 169 |
|
|
2019
Q4 | $1.94M | Sell |
12,931
-225
| -2% | -$32.8K | 0.48% | 56 |
|
|
2019
Q3 | $1.87M | Sell |
13,156
-135
| -1% | -$18.6K | 0.48% | 57 |
|
|
2019
Q2 | $1.66M | Sell |
13,291
-223
| -2% | -$26.3K | 0.42% | 65 |
|
|
2019
Q1 | $1.49M | Sell |
13,514
-4,613
| -25% | -$480K | 0.38% | 74 |
|
|
2018
Q4 | $1.78M | Buy |
18,127
+1,762
| +11% | +$191K | 0.49% | 52 |
|
|
2018
Q3 | $2.02M | Hold |
16,365
| – | – | 0.51% | 44 |
|
|
2018
Q2 | $1.63M | Buy |
16,365
+350
| +2% | +$32.2K | 0.43% | 48 |
|
|
2018
Q1 | $1.41M | Sell |
16,015
-1,435
| -8% | -$134K | 0.38% | 51 |
|
|
2017
Q4 | $1.72M | Buy |
17,450
+150
| +0.9% | +$14.7K | 0.47% | 48 |
|
|
2017
Q3 | $1.67M | Hold |
17,300
| – | – | 0.47% | 47 |
|
|
2017
Q2 | $1.64M | Buy |
17,300
+1,245
| +8% | +$115K | 0.45% | 47 |
|
|
2017
Q1 | $1.31M | Sell |
16,055
-1,245
| -7% | -$104K | 0.37% | 58 |
|
|
2016
Q4 | $1.47M | Buy |
17,300
+3,200
| +23% | +$252K | 0.43% | 54 |
|
|
2016
Q3 | $1.05M | Hold |
14,100
| – | – | 0.33% | 63 |
|
|
2016
Q2 | $1.07M | Sell |
14,100
-7,450
| -35% | -$542K | 0.33% | 59 |
|
|
2016
Q1 | $1.49M | Hold |
21,550
| – | – | 0.47% | 46 |
|
|
2015
Q4 | $1.3M | Hold |
21,550
| – | – | 0.42% | 52 |
|
|
2015
Q3 | $1.17M | Sell |
21,550
-300
| -1% | -$17.5K | 0.39% | 49 |
|
|
2015
Q2 | $1.27M | Buy |
21,850
+100
| +0.5% | +$5.58K | 0.36% | 57 |
|
|
2015
Q1 | $1.31M | Buy |
21,750
+650
| +3% | +$34.6K | 0.38% | 53 |
|
|
2014
Q4 | $1.12M | Hold |
21,100
| – | – | 0.34% | 58 |
|
|
2014
Q3 | $944K | Buy |
21,100
+200
| +1% | +$8.5K | 0.29% | 70 |
|
|
2014
Q2 | $882K | Hold |
20,900
| – | – | 0.35% | 60 |
|
|
2014
Q1 | $921K | Sell |
20,900
-4,650
| -18% | -$219K | 0.38% | 56 |
|
|
2013
Q4 | $1.25M | Hold |
25,550
| – | – | 0.52% | 45 |
|
|
2013
Q3 | $1.05M | Hold |
25,550
| – | – | 0.48% | 46 |
|
|
2013
Q2 | $898K | Buy |
+25,550
| New | +$841K | 0.44% | 48 |
|
Other funds holding WST
Chatham Capital Group's WST Position: Q2 2022 in Review
Chatham Capital Group sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 508 shares — an estimated $209K sold.
Chatham Capital Group first reported a position in WST in Q2 2013 and held it in 35 quarters. The position peaked at $2.02M in Q3 2018. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.
- Chatham Capital Group reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
- Chatham Capital Group sold 508 West Pharmaceutical shares in Q2 2022, an estimated $209K.
- Chatham Capital Group first reported a position in West Pharmaceutical in Q2 2013 and held it in 35 quarters.
- Chatham Capital Group's West Pharmaceutical position peaked at $2.02M in Q3 2018.
- 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.
Based on Chatham Capital Group's 13F filing for Q2 2022, filed 2 Aug 2022.